Nucleus incertus contributes to an anxiogenic effect of buspirone in rats: Involvement of 5-HT1A receptors

被引:23
|
作者
Kumar, Jigna Rajesh [1 ,2 ,3 ,4 ]
Rajkumar, Ramamoorthy [1 ,2 ,3 ]
Lee, Liying Corinne [1 ,2 ,3 ]
Dawe, Gavin S. [1 ,2 ,3 ,4 ]
机构
[1] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117600, Singapore
[2] Natl Univ Singapore, Inst Life Sci, Neurobiol & Ageing Programme, Singapore 117456, Singapore
[3] Singapore Inst Neurotechnol SINAPSE, Singapore 117456, Singapore
[4] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn NGS, Singapore 117456, Singapore
基金
英国医学研究理事会;
关键词
Buspirone; Nucleus incertus; Anxiogenic; 5-HT1A receptors; D-2; receptors; ELEVATED PLUS-MAZE; CORTICOTROPIN-RELEASING-FACTOR; IMMEDIATE-EARLY GENE; C-FOS; ADENYLATE-CYCLASE; PHARMACOLOGICAL CHARACTERIZATION; POTENTIATED STARTLE; DORSAL HIPPOCAMPUS; LOCUS-COERULEUS; PANIC DISORDER;
D O I
10.1016/j.neuropharm.2016.07.019
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The nucleus incertus (NI), a brainstem structure with diverse anatomical connections, is implicated in anxiety, arousal, hippocampal theta modulation, and stress responses. It expresses a variety of neurotransmitters, neuropeptides and receptors such as 5-HT1A, D-2 and CRF1 receptors. We hypothesized that the NI may play a role in the neuropharmacology of buspirone, a clinical anxiolytic which is a 5-HT1A receptor partial agonist and a D-2 receptor antagonist. Several preclinical studies have reported a biphasic anxiety-modulating effect of buspirone but the precise mechanism and structures underlying this effect are not well-understood. The present study implicates the NI in the anxiogenic effects of a high dose of buspirone. Systemic buspirone (3 mg/kg) induced anxiogenic effects in elevated plus maze, light-dark box and open field exploration paradigms in rats and strongly activated the NI, as reflected by c-Fos expression. This anxiogenic effect was reproduced by direct infusion of buspirone (5 mu g) into the NI, but was abolished in NI-CRF-saporin-lesioned rats, indicating that the NI is present in neural circuits driving anxiogenic behaviour. Pharmacological studies with NAD 299, a selective 5-HT1A antagonist, or quinpirole, a D-2/D-3 agonist, were conducted to examine the receptor system in the NI involved in this anxiogenic effect. Opposing the 5-HT1A agonism but not the D-2 antagonism of buspirone in the NI attenuated the anxiogenic effects of systemic buspirone. In conclusion, 5-HT1A receptors in the NI contribute to the anxiogenic effect of an acute high dose of buspirone in rats and may be functionally relevant to physiological anxiety. (C) 2016 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 50 条
  • [1] EVIDENCE FOR THE INVOLVEMENT OF 5-HT1A RECEPTORS IN THE ANTICONFLICT EFFECT OF IPSAPIRONE IN RATS
    CHOJNACKAWOJCIK, E
    PRZEGALINSKI, E
    NEUROPHARMACOLOGY, 1991, 30 (07) : 703 - 709
  • [2] 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus
    Dos Santos, Lucineia
    de Andrade, Telma G. C. S.
    Junior, Helio Zangrossi
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (04) : 286 - 294
  • [3] Involvement of 5-HT1A receptors into the dorsal hippocampus in the hypophagic effect caused by fluoxetine in rats
    Scopinho, America Augusto
    de Aguiar Correa, Fernando Morgan
    Moraes Resstel, Leonardo Barbosa
    FASEB JOURNAL, 2013, 27
  • [4] Involvement of 5-HT1A receptors in the consolidation of learning in cognitively impaired rats
    Meneses, A
    Terrón, JA
    Hong, E
    ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 : 286 - 287
  • [5] Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors
    Sagarduy, A.
    Llorente, J.
    Miguelez, C.
    Morera-Herreras, T.
    Ruiz-Ortega, J. A.
    Ugedo, L.
    EXPERIMENTAL NEUROLOGY, 2016, 277 : 35 - 45
  • [6] Antinociceptive effect of the agonist of 5-HT1A receptors buspirone in the model of abdominal pain in dogs
    Lyubashina O.A.
    Busygina I.I.
    Panteleev S.S.
    Nozdrachev A.D.
    Doklady Biological Sciences, 2017, 473 (1) : 46 - 49
  • [7] Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment
    Vicente, Maria Adrielle
    Zangrossi, Helio, Jr.
    NEUROPHARMACOLOGY, 2014, 79 : 127 - 135
  • [8] 5-HT1A RECEPTORS IN THE MEDIAN RAPHE NUCLEUS AND DORSAL HIPPOCAMPUS MAY MEDIATE ANXIOLYTIC AND ANXIOGENIC BEHAVIORS RESPECTIVELY
    ANDREWS, N
    HOGG, S
    GONZALEZ, LE
    FILE, SE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 264 (03) : 259 - 264
  • [9] Rigid analogues of buspirone and gepirone, 5-HT1A receptors partial agonists
    Chilmonczyk, Z
    Krajewski, KJ
    Cybulski, J
    FARMACO, 2002, 57 (11): : 917 - 923
  • [10] Involvement of postsynaptic 5-HT1A receptors in the therapeutic effect of antidepressant treatment
    de Montigny, C
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R371 - R371